Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “neuroprotective”

21 pharma patents match "neuroprotective" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 21
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 21 pharmaceutical patents matching "neuroprotective" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

21 results for “neuroprotective” · 30,257 patents in full index Clear search

  1. US 11974988

    Neuroprotective compositions and methods of using the same

    The Regents of the University of California · Granted May 7, 2024 · Expires May 2, 2044

    granted
  2. US 11970521

    Neuroprotective beta amyloid core peptides and peptidomimetic derivatives

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  3. US 11872312

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  4. US 11471502

    Neuroprotective peptide

    University College Cardiff Consultants Limited · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  5. US 11414379

    SPAK kinase inhibitors as neuroprotective agents

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  6. US 11273130

    Methods of delivering a neuroprotective polypeptide to the central nervous system

    The United States, as represented by the Secretary Department of Health and Human Services · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  7. US 11147795

    Neuroprotective compounds and methods of use

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  8. US 10995061

    SPAK kinase inhibitors as neuroprotective agents

    United States Government as represented by the Department of Veterans Affairs · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  9. US 10973764

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  10. US 10369103

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  11. US 9902713

    Neuroprotective compounds and use thereof

    The Board of Regents of the University of Texas System · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  12. US 9645139

    Neuroprotective chemicals and methods for identifying and using same

    The Board of Regents of the University of Texas System · Granted May 9, 2017 · Expires May 4, 2037

    granted
  13. US 9243281

    Neuroprotective chemicals and methods for identifying and using same

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  14. US 9205119

    Neuroprotective compositions and methods

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted
  15. US 8350077

    Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity

    Vertex Closed Joint Stock Company · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  16. US 8329719

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  17. US 8058268

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  18. US 8030493

    Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, geroprotective and cerebroprotective action

    Obschestvo S Ogranichennoy Otvetstvennostyu “Natsionalnaya Isseldovatelskaya Kompaniya” · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  19. US 7022882

    NMDA receptor channel blocker with neuroprotective activity

    The Regents of the University of California · Granted Apr 4, 2006 · Expires Mar 30, 2026

    expired
  20. US 6410537

    Compositions having neuroprotective and analgesic activity

    The United States of America as represented by the Secretary of the Army · Granted Jun 25, 2002 · Expires Jun 20, 2022

    expired
  21. US 6046200

    Compositions having neuroprotective and analgesic activity

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 4, 2000 · Expires Mar 30, 2020

    expired